Literature DB >> 33039343

Effects of Intra-Articular Resveratrol Injections on Cartilage Destruction and Synovial Inflammation in Experimental Temporomandibular Joint Osteoarthritis.

Pinar Yuce1, Hatice Hosgor2, Selenay Furat Rencber3, Yusufhan Yazir4.   

Abstract

PURPOSE: The aim of this study was to investigate the effects of intra-articular resveratrol injections on cartilage destruction and synovial inflammation in an experimental temporomandibular joint osteoarthritis (TMJ-OA) model.
MATERIALS AND METHODS: Freund's complete adjuvant injection method was used to construct the TMJ-OA model. Twenty-eight male Wistar rats were randomly placed into 4 groups: control (n = 4), TMJ arthritis (n = 8), low-dose intra-articular resveratrol (RES[L]; n = 8), and high-dose intra-articular resveratrol (RES[H]; n = 8). Intra-articular injections of resveratrol were performed 3 times at 1-week intervals, 1 week after the administration of a single dose of Freund's complete adjuvant to the TMJ. The effects of resveratrol on cartilage destruction and synovial inflammation were examined histopathologically. The histomorphometric examination revealed condylar cartilage and articular disc thickness. An apoptotic chondrocyte count was performed with terminal deoxynucleotidyl transferase dUTP nick end labeling staining, and matrix metalloproteinase 13 expression was evaluated through an immunohistochemical examination.
RESULTS: The thickness of the condylar cartilage in the RES(L) and RES(H) groups was statistically significantly greater than that in the control and TMJ arthritis groups (P < .05). The inflammation-induced articular disc thickening was significantly lower in the RES(L) and RES(H) groups (P < .05). The chondrocyte apoptosis in the RES(L) and RES(H) groups was significantly lower than that in the TMJ arthritis group (P < .05). The matrix metalloproteinase 13 expression in the RES(L) and RES(H) groups was obviously less than that in the TMJ arthritis group (P < .05).
CONCLUSIONS: The intra-articular resveratrol treatment exerted a curative effect by preventing the inflammation and cartilage destruction associated with TMJ-OA.
Copyright © 2020 American Association of Oral and Maxillofacial Surgeons. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2020        PMID: 33039343     DOI: 10.1016/j.joms.2020.09.015

Source DB:  PubMed          Journal:  J Oral Maxillofac Surg        ISSN: 0278-2391            Impact factor:   1.895


  4 in total

Review 1.  Therapeutic Single Compounds for Osteoarthritis Treatment.

Authors:  Hyemi Lee; Xiangyu Zhao; Young-Ok Son; Siyoung Yang
Journal:  Pharmaceuticals (Basel)       Date:  2021-02-06

Review 2.  Botanical Drug Extracts Combined With Biomaterial Carriers for Osteoarthritis Cartilage Degeneration Treatment: A Review of 10 Years of Research.

Authors:  Panyun Mu; Jie Feng; Yimei Hu; Feng Xiong; Xu Ma; Linling Tian
Journal:  Front Pharmacol       Date:  2022-01-31       Impact factor: 5.810

3.  The Antioxidant Resveratrol Protects against Chondrocyte Apoptosis by Regulating the COX-2/NF-κB Pathway in Created Temporomandibular Osteoarthritis.

Authors:  Wen Li; Shiyu Hu; Xuepeng Chen; Jiejun Shi
Journal:  Biomed Res Int       Date:  2021-07-09       Impact factor: 3.411

4.  Primary Osteoarthritis Early Joint Degeneration Induced by Endoplasmic Reticulum Stress Is Mitigated by Resveratrol.

Authors:  Jacqueline T Hecht; Alka C Veerisetty; Juliana Wu; Francoise Coustry; Mohammad G Hossain; Frankie Chiu; Francis H Gannon; Karen L Posey
Journal:  Am J Pathol       Date:  2021-06-08       Impact factor: 5.770

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.